收藏切换
Research status of omics technology in the research of prevention and treatment of pulmonary fibrosis with traditional Chinese medicine
收藏切换
PDF
Ni-ni LIAN1, 2, Ya-li LUO1, 2, 3, Lin-feng RUAN1, 2, Jing LUO1, 2, Li FENG1, 2, Xin-ru DENG1, 2
Chinese Journal of Clinical Pharmacology | 2025, 41(4) : 570 - 575
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(4): 570-575
Review
Research status of omics technology in the research of prevention and treatment of pulmonary fibrosis with traditional Chinese medicine
Full
Ni-ni LIAN1, 2, Ya-li LUO1, 2, 3, Lin-feng RUAN1, 2, Jing LUO1, 2, Li FENG1, 2, Xin-ru DENG1, 2
Affiliations
  • 1.Basic Medical College, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China
  • 2.Provincial Key Laboratory of Molecular Medicine and TCM for the Prevention and Treatment of Major Diseases in Colleges and Universities of Gansu Province, Lanzhou 730000, Gansu Province, China
  • 3.Key Laboratory of Dunhuang Medicine and Translational of Ministry of Education, Lanzhou 730000, Gansu Province, China
Published: 2025-02-28 doi: 10.13699/j.cnki.1001-6821.2025.04.025
Outline
收藏切换

Pulmonary fibrosis (PF) is a kind of interstitial lung disease with unknown cause. The mechanism of traditional Chinese medicine in the prevention and treatment of PF needs to be strengthened. Traditional Chinese medicine and its compounds can play a therapeutic role in the prevention and treatment of PF from multiple targets and pathways. Because of the complex components of traditional Chinese medicine and single research method, the research process is slow. In recent years, omics technologies (proteomics, metabolomics, transcriptomics, genomics) are helpful to explore and screen clinical biomarkers and new prevention and treatment targets of PF, providing ideas and strategies for the development of targeted traditional Chinese medicine. In this review, we summarize the application of different omics technologies in the research of PF in recent years, and analyze the progress of omics technology in revealing the therapeutic mechanism of traditional Chinese medicine. We also discuss the advantages and limitations of omics technology, and think about the future research direction of PF.

Chinese medicine  /  pulmonary fibrosis  /  omics technology  /  effect mechanism
Ni-ni LIAN, Ya-li LUO, Lin-feng RUAN, Jing LUO, Li FENG, Xin-ru DENG. Research status of omics technology in the research of prevention and treatment of pulmonary fibrosis with traditional Chinese medicine[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (4) : 570 -575 . DOI: 10.13699/j.cnki.1001-6821.2025.04.025
Year 2025 volume 41 Issue 4
PDF
0
0
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.04.025
  • Receive Date:2024-08-15
  • Online Date:2026-08-04
  • Published:2025-02-28
Article Data
Affiliations
History
  • Received:2024-08-15
Funding
Affiliations
    1.Basic Medical College, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China
    2.Provincial Key Laboratory of Molecular Medicine and TCM for the Prevention and Treatment of Major Diseases in Colleges and Universities of Gansu Province, Lanzhou 730000, Gansu Province, China
    3.Key Laboratory of Dunhuang Medicine and Translational of Ministry of Education, Lanzhou 730000, Gansu Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.04.025
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT